Invited commentary: Low cholesterol and nonatherosclerotic disease risk: A persistently perplexing question

American Journal of Epidemiology

Volumn 151, Issue 8, 2000, Pages 748-751

  Jacobs Jr , David R ^a   Iribarren, Carlos ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Cholesterol; Colonic neoplasms; Coronary disease; Liver neoplasms; Mortality; Neoplasms

Indexed keywords

CHOLESTEROL;

ARTICLE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COLON CANCER; CORONARY ARTERY DISEASE; HUMAN; LIVER CANCER; MALE; MORTALITY; RISK FACTOR;

EID: 0342757863     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010273     Document Type: Article

References (36)

1. Song Y-M, Sung J, Kim JS. Which cholesterol level is related to the lowest mortality in a population with low mean cholesterol level: a 6.4-year follow-up study of 482,472 Korean men. Am J Epidemiol 2000;151:739-47
2. Frank JW, Reed DM, Grove JS, et al. Will lowering population levels of serum cholesterol affect total mortality? Expectations from the Honolulu Heart Program. J Clin Epidemiol 1992;45: 333-46.
3. Rosengren A, Hagman M, Wedel H, et al. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris. A 16-year follow-up of the Primary Prevention Study in Goteborg, Sweden. Eur Heart J 1997;18:754-61.
4. Grant MD, Piotrowski ZH, Miles TP. Declining cholesterol and mortality in a sample of older nursing home residents. J Am Geriatr Soc 1996;44:31-6.
5. Noel MA, Smith TK, Ettinger WH. Characteristics and outcomes of hospitalized older patients who develop hypocholesterolemia. J Am Geriatr Soc 1991;39:455-61.
6. Jacobs DR Jr, Hebert B, Schreiner PJ, et al. Reduced cholesterol is associated with minor recent illness: the CARDIA Study. Am J Epidemiol 1997;146:558-64.
7. Iribarren C, Reed DM, Yano K, et al. Low cholesterol and mortality: which is the cause and which is the effect? Circulation 1995;92:2396-403.
8. Iribarren C, Reed DM, Burchfiel CM, et al. Serum total cholesterol and mortality. Confounding factors and risk modification in Japanese-American men. JAMA 1995;273:1926-32.
9. Cullen P, Schulte H, Assmann G. The Munster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation 1997;96:2128-36.
10. Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-60.
11. Meilahn EN, Ferrell RE. 'Naturally occurring' low blood cholesterol and excess mortality. Coron Artery Dis 1993;4: 843-53.
12. Iribarren C, Jacobs DR Jr, Sidney S, et al. Low total cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. Stroke 1996;27:1993-8.
13. Iribarren C, Jacobs DR Jr, Sidney S, et al. Serum total cholesterol and risk of hospitalization and death by respiratory disease in a large cohort. Int J Epidemiol 1997;26:1191-202.
14. Claxton AJ, Jacobs DR Jr, Iribarren C, et al. The association between serum total cholesterol and HIV infection in a high risk cohort of young men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:51-7.
15. Iribarren C, Jacobs DR Jr, Sidney S, et al. Cohort study of serum cholesterol and in-hospital incidence of infectious diseases. Epidemiol Infect 1998;121:335-47.
16. Gould AL, Rossouw JE, Santanello NC, et al. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 1995;91:2274-82.
17. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-57.
18. Pfeffer MA, Sacks FM, Moye LA, et al. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol and recurrent events. J Am Coll Cardiol 1999;33: 125-30.
19. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Preventions Study. JAMA 1998;279:1615-22.
20. Muldoon MF, Kritchevsky SB, Evans RW, et al. Serum total antioxidant activity in relative hypo- and hypercholesterolemia. Free Radic Res 1996;25:239-45.
21. Iribarren C, Lowry PW, Gross MD, et al. Influence of total serum cholesterol and lipid-soluble vitamins in immune response among healthy young adults. Environ Nutr Int 1998; 2:127-38.
22. Feingold KR, Funk JL, Moser AH, et al. Role of circulating lipoproteins in protection from endotoxin toxicity. Infect Immun 1995;63:2041-6.
23. Golomb BA. Cholesterol and violence: is there a connection? Ann Intern Med 1998;128:478-87.
24. Kaplan JR, Muldoon MF, Manuck SB, et al. Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk. Ann N Y Acad Sci 1997;836:57-80.
25. Markovitz JH, Smith D, Raczynski JM, et al. Lack of relations of hostility, negative affect, and high-risk behavior with low plasma lipid levels in the Coronary Artery Risk Development in Young Adults Study. Arch Intern Med 1997;157:1953-9.
26. Fernstrom MH, Verrico CD, Ebaugh AL, et al. Diet-induced changes in serum cholesterol concentrations do not alter tryptophan hydroxylation rate or serotonin concentrations in gerbil brain. Life Sci 1996;58:1433-44.
27. Maes M, Smith R, Christophe A, et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand 1997;95:212-21.
28. Smith RS. The macrophage theory of depression. Med Hypotheses 1991;35:298-306.
29. Penttinen J. Hypothesis: low serum cholesterol, suicide, and interleukin-2. Am J Epidemiol 1995;141:716-18.
30. Christensen L, Somers S. Adequacy of the dietary intake of depressed individuals. J Am Coll Nutr 1994;13:597-600.
31. Magni G, Garreau M, Orofiamma B, et al. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics. Neuropsychobiology 1989;20:126-31.
32. Ettinger WH Jr, Harris T, Verdery RB, et al. Evidence for inflammation as a cause of hypocholesterolemia in older people. J Am Geriatr Soc 1995;43:264-6.
33. Chen Z, Keech A, Collins R, et al. Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer. BMJ 1993;306:890-4.
34. Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993;328:313-18.
35. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, et al. Total cholesterol and risk of mortality in the oldest old. Lancet 1997;350:1119-23.
36. Corti MC, Barbato GM, Baggio G. Lipoprotein alterations and atherosclerosis in the elderly. Curr Opin Lipidol 1997;8: 236-41.